Skoči na glavni sadržaj

Recenzija, Prikaz slučaja

Hormone Replacement Therapy – Is There a Place for Its Use in Neurology?

Vlasta Vuković
Arijana Lovrenčić-Huzjan
Vesna Vargek Solter
Veljko Đorđević
Vida Demarin


Puni tekst: engleski pdf 88 Kb

str. 413-424

preuzimanja: 659

citiraj


Sažetak

Stroke remains the third leading cause of mortality in developed countries despite
declining tendency over the past decades. As the leading cause of disability and second
cause of dementia, primary prevention should be the main way to fight the disease, since
therapy is not efficient enough. Several observations pointed to estrogen as a protective
agent that may reduce stroke risk, however, studies have shown conflicting data. There
is no strong evidence that hormone replacement therapy (HRT) increases stroke risk.
Several studies have shown that HRT may reduce the risk of fatal stroke. Conflicting results
have been found for Alzheimer’s disease and HRT as well. An association between
higher serum concentration of estradiol and decreased risk of cognitive decline has been
found in some studies, supporting the hypothesis that estrogen concentration may play
a significant role in brain protection. Having in mind results of recent randomized trials,
it is suggested that HRT should not be recommended on general basis for the primary
or secondary prevention of cardiovascular/cerebrovascular diseases or for primary
prevention of degenerative diseases such as Alzheimer’s disease. Osteoporosis,
cognitive decline and climacteric symptoms that are likely to impact on quality of life,
speak in favor for recommendation of HRT use. On the other side, family history of
breast carcinoma, mastopathy, thromboembolism, in certain cases gallbladder disease,
will discourage the commencement of HRT. Respecting the patient’s preferences and
having benefits and risks in mind as well as science advisory statements, individual
counseling regarding HRT should be the leading concept in the healthcare of postmenopausal
women.

Ključne riječi

hormone replacement therapy; stroke; postmenopause

Hrčak ID:

28107

URI

https://hrcak.srce.hr/28107

Datum izdavanja:

16.6.2003.

Posjeta: 1.062 *